Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Gynecol Oncol. 2019 Dec 16;156(2):467–474. doi: 10.1016/j.ygyno.2019.10.009

Table 3.

Comorbidities Identified in Evaluable Patients

Cancer Type Vascular Insufficiency Infection Infection + Vascular Insufficiency VTE VTE + Infection
Endometrial (n=734) 3 (0.4%) 22 (3.0%) 1 (0.1%) 4 (0.5% 1 (0.1%)
Cervical (n=138) 9 (6.5%) 1 (0.7%) 1 (0.7%)
Vulvar (n=42) 1 (2.4%) 11 (26.2%) 2 (4.8%)

VTE, venous thromboembolism